Dublin-based Venn Life Sciences records 57% rise in 2016 income
Firm says it secured €5.7 million worth of contract deals in first two months of 2017
Venn sells Innovenn for €5.4m all-share deal
Clinical trials group selling technology development subsidiary to UK firm Integumen
Income more than doubles at clinical trials group Venn
Investment in synthetic skin project that is being sold widens operating loss
Sales surge at clinical trials group Venn Life Sciences
Company reports maiden Ebitda profit before exceptionals on strong sales and Kinesis acquisition
Venn Life Sciences reports 32% rise in revenue on back of new contracts
Clinical trials group continues to integrate acquisitions and eye new targets
Clinical trials group Venn buys synthetic skin technology
Acquisition of LabSkin from Evocutis will address EU ban on animal testing for skincare and cosmetic products
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices